Jian Li

Title: Jian Li: Shanghai's Innovator with Over 133 Patents

Introduction:

In the realm of innovation and patents, Jian Li has made a significant impact with his extensive portfolio of patents and groundbreaking inventions. Based in Shanghai, China, Li's contributions have made him a notable figure within the industry. This article explores Li's latest patents, career highlights, and collaborative endeavors.

Latest Patents:

Jian Li has recently unveiled two impressive patents, showcasing his expertise in the field:

1. Benzo 2-azaspiro[4.4]nonane compound and use thereof:

This patent discloses a series of benzo 2-azaspiro[4.4]nonane compounds, with a special emphasis on a specific compound represented by formula (P) or its pharmaceutically acceptable salts. These compounds hold potential for various pharmaceutical applications.

2. Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound:

Another notable patent by Li involves a crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound, along with its preparation method. This crystal form finds application in the development of medicines to treat related diseases.

Career Highlights:

Throughout his career, Jian Li has made significant strides in the field of innovation. Here are some career highlights:

1. Medshine Discovery Inc.:

Li has been associated with Medshine Discovery Inc., a prominent pharmaceutical research and development company. His contributions to the company have played a crucial role in advancing drug discovery and development processes.

2. Chia Tai Tianqing Pharmaceutical Group:

Li has also worked with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. This collaboration demonstrates his commitment to partnering with influential industry players to bring innovative healthcare solutions to the market.

Collaborations:

Jian Li has actively engaged in collaborations with fellow professionals, fostering a collective spirit of innovation and knowledge sharing. Notably, he has collaborated closely with Shuhui Chen, a respected figure in the field. Their joint efforts have led to groundbreaking advancements and further established Li's position as a leading innovator.

Conclusion:

Jian Li's impressive collection of over 133 patents and notable career highlights clearly depict his commitment to innovation and expertise in the pharmaceutical field. With his recent patents focusing on new compounds and crystal forms with medical applications, Li continues to make a significant impact. Collaborations with industry leaders like Shuhui Chen further solidify his standing as a respected innovator. As Shanghai's own innovator, Jian Li is undoubtedly shaping the future of the pharmaceutical industry with his inventive contributions.